FDA fast-tracks review of elinzanetant for hot flashes linked to breast cancer treatment. Here’s what the trial found and what patients should know.
|Articles|September 14, 2022
Breast Cancer and Social Media
Advertisement
Social media can provide a sense of support to those who don't have a huge community to turn to. However, it also is a downfall when it comes to the spread of misinformation. Take a deeper read into this blog as Alexis Puthussery shares the pros and cons of social media in a breast cancer space.
Advertisement
Related to this article
After two relapses, CAR T-cell therapy and a stem cell transplant, William Yank is in remission. But infertility, mental health challenges and a changed sense of self followed him into survivorship.
A phase 3 trial found proton therapy did not help people with advanced liver cancer live longer than standard photon radiation therapy.
A breast surgeon explains how rebuilding the breast with a person's own tissue and new tools may boost satisfaction and cut repeat surgery.
Some patients with lymphoma show no detectable cancer by day 8 of treatment, and a lymphoma specialist explains how early testing could guide care.
Life after cancer can bring lasting physical, financial and emotional challenges, especially for young survivors navigating life after treatment.
Dr. Maurie Markman discusses how AI could support primary care doctors and specialists caring for patients with cancer while keeping physicians at the center.
A combination of Zenbexus, Darzalex and dexamethasone nearly doubled the rate of deep, MRD-negative responses in relapsed multiple myeloma.
Advertisement
Advertisement
Trending on CURE
1
Zenbexus Combo Nearly Doubles Deep Responses in Relapsed Myeloma
2
Hot Flashes From Breast Cancer Treatment May Soon Have an FDA-Approved Fix
3
A Breast Surgeon Explains Lumpectomy, Mastectomy and Recovery
4
Why Early Response Testing Could Reshape Lymphoma Treatment
5